Global pharmaceutical company Allergan has confirmed that it has received Food and Drug Administration (FDA) approval to market JUVÉDERM VOLLURE XC for the correction of moderate to severe facial wrinkles and folds in the US.
Microneedling device, SkinPen Precision, by Bellus Medical has been cleared by the Food and Drug Administration (FDA), which, according to the company, is the first device of its kind to have received the clearance.
Global pharmaceutical company Allergan and biopharmaceutical company Paratek have confirmed that two phase 3 trials of sarecycline met their 12-week primary efficacy endpoints.
Attendees were greeted at the Natural History Museum with drinks and canapés for the CoolSculpting event on September 22.
The Food and Drug Administration (FDA) has expressed its concerns over some manufacturers that are marketing devices for vaginal rejuvenation as suitable for treating indications related to stress urinary incontinence (SUI), menopause or sexual function.
In December, global pharmaceutical company Allergan celebrated the beginning of the 30th anniversary celebration for Botox with the ringing of the New York Stock Exchange opening bell.
The Cosmex Clinic revealed its new CoolSculpting treatment at its open evening in Cambridge on September 28.
Global pharmaceutical company Allergan has launched a new advertising campaign for its dermal filler Juvéderm which will be launched internationally in Spring 2019.
A report on the 15th annual Aesthetic and Anti- Aging Medicine World Congress in Monte Carlo on the 6-8 of April 2017
The Lightfusion LED platform has been approved by the US Food and Drug Administration (FDA) as a Class 2 medical device for the treatment of periorbital wrinkles.